Loading clinical trials...
Loading clinical trials...
This study aims to analyze the effects of AI-based risk prediction for graft loss on the frequency of conversations about the treatment after graft loss, as well as the associated shared decision maki...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Charite University, Berlin, Germany
NCT05325008 · BK Viremia, Kidney Transplant Infection, and more
NCT05525507 · End Stage Kidney Disease, Immunological Tolerance, and more
NCT05788276 · Kidney Transplant; Complications, Kidney Transplant Failure, and more
NCT05806749 · End Stage Kidney Disease, Immunological Tolerance, and more
NCT03380962 · Kidney Failure, Chronic, End-Stage Renal Disease, and more
Charité - Universitätsmedizin Berlin
Berlin, State of Berlin
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions